Chenglong Wang

834 total citations
39 papers, 612 citations indexed

About

Chenglong Wang is a scholar working on Cancer Research, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chenglong Wang has authored 39 papers receiving a total of 612 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 15 papers in Molecular Biology and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chenglong Wang's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (8 papers). Chenglong Wang is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (9 papers) and Circular RNAs in diseases (8 papers). Chenglong Wang collaborates with scholars based in China, United States and Italy. Chenglong Wang's co-authors include Peili Wang, Jinghui Sun, Jiangang Liu, Alessandro Reali, Michael Wu, David Kamensky, Josef Kiendl, Ming‐Chen Hsu, Yuri Bazilevs and Michael S. Sacks and has published in prestigious journals such as Scientific Reports, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Chenglong Wang

36 papers receiving 603 citations

Peers

Chenglong Wang

CCM

CAM

Qingtian Zhu China

Ye Wang China

Xuefu Wang China

Yang Cui China

Shuai Mao China

Boliang Wang China

Fangda Fu China

Chunguang Yan China

Yanjun Lin China

Qingtian Zhu China

Chenglong Wang

328 ×1.4

57 ×0.4

CCM

23 ×0.2

34 ×0.3

25 ×0.3

CAM

Citations per year, relative to Chenglong Wang Chenglong Wang (= 1×) peers Qingtian Zhu

Countries citing papers authored by Chenglong Wang

Since Specialization

Citations

This map shows the geographic impact of Chenglong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenglong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenglong Wang more than expected).

Fields of papers citing papers by Chenglong Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenglong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenglong Wang. The network helps show where Chenglong Wang may publish in the future.

Co-authorship network of co-authors of Chenglong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Chenglong Wang. A scholar is included among the top collaborators of Chenglong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenglong Wang. Chenglong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Mingzhe, et al.. (2025). Accelerometry-Based Physical Activity and Sedentary Behavior Among Chinese Adults — 7 PLADs, China, 2023. China CDC Weekly. 7(1). 15–20. 1 indexed citations

Yang, Li, et al.. (2025). piRNA DQ690018 increased bone mass by promoting the proliferation and osteogenic differentiation of BMSCs. Journal of Orthopaedic Surgery and Research. 21(1). 29–29.

Zhao, Zhiqiang, Shuai Wang, Jun Li, et al.. (2024). Efficacy and Safety of Jiuxin Pill in the Treatment of Patients with Stable Angina Pectoris: A Protocol for a Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial. International Journal of General Medicine. Volume 17. 4711–4722.

Zhang, Xinhai, Xuyi Wang, Chenglong Wang, et al.. (2024). PiRNA hsa_piR_019949 promotes chondrocyte anabolic metabolism by inhibiting the expression of lncRNA NEAT1. Journal of Orthopaedic Surgery and Research. 19(1). 31–31. 2 indexed citations

Wang, Chenglong, et al.. (2023). Effect of omega-3 fatty acids supplementation on the prognosis of coronary artery disease: A meta-analysis of randomized controlled trials. Nutrition Metabolism and Cardiovascular Diseases. 34(3). 537–547. 4 indexed citations

Chen, Yunru, et al.. (2023). Refractory angina pectoris: a 20-year (2003–2022) bibliometric analysis. Frontiers in Cardiovascular Medicine. 10. 1228201–1228201. 2 indexed citations

Sun, Jinghui, et al.. (2023). The Role of miRNA in the Regulation of Angiogenesis in Ischemic Heart Disease. Current Problems in Cardiology. 48(6). 101637–101637. 8 indexed citations

Zhao, Na, Yumei Li, Chenglong Wang, et al.. (2022). DJ-1 activates the Atg5-Atg12-Atg16L1 complex via Sirt1 to influence microglial polarization and alleviate cerebral ischemia/reperfusion-induced inflammatory injury. Neurochemistry International. 157. 105341–105341. 18 indexed citations

Li, Xin, Jia Yuan, Xiaolin Xu, et al.. (2022). The miR-33a-5p/CROT axis mediates ovarian cancer cell behaviors and chemoresistance via the regulation of the TGF-β signal pathway. Frontiers in Endocrinology. 13. 950345–950345. 7 indexed citations

10.

Xiao, Fei, Chenglong Wang, Jianping Peng, et al.. (2022). Changes in Small Noncoding RNA Expression during Chondrocyte Senescence. Cartilage. 13(3). 765206765–765206765. 3 indexed citations

11.

Sun, Jinghui, et al.. (2021). Long Noncoding RNAs Involved in Cardiomyocyte Apoptosis Triggered by Different Stressors. Journal of Cardiovascular Translational Research. 15(3). 588–603. 4 indexed citations

12.

Zhang, Pei, et al.. (2020). Panax quinquefolium saponin Optimizes Energy Homeostasis by Modulating AMPK-Activated Metabolic Pathways in Hypoxia-Reperfusion Induced Cardiomyocytes. Chinese Journal of Integrative Medicine. 27(8). 613–620. 7 indexed citations

13.

Wang, Peili, et al.. (2019). The efficacy of Chinese herbal medicines on acute coronary syndrome with renal insufficiency after percutaneous coronary intervention. Journal of Ethnopharmacology. 248. 112354–112354. 11 indexed citations

14.

Sun, Jinghui & Chenglong Wang. (2019). Long non-coding RNAs in cardiac hypertrophy. Heart Failure Reviews. 25(6). 1037–1045. 13 indexed citations

15.

Wang, Chenglong, Jianping Peng, & Xiaohong Chen. (2018). LncRNA-CIR promotes articular cartilage degeneration in osteoarthritis by regulating autophagy. Biochemical and Biophysical Research Communications. 505(3). 692–698. 35 indexed citations

16.

Wang, Peili, et al.. (2017). Panax notoginsengPreparations for Unstable Angina Pectoris: A Systematic Review and Meta-Analysis. Phytotherapy Research. 31(8). 1162–1172. 33 indexed citations

17.

Dong, Jie, Shaohua Li, Wei Xia, et al.. (2017). An alternative microRNA-mediated post-transcriptional regulation of GADD45A by p53 in human non-small-cell lung cancer cells. Scientific Reports. 7(1). 7153–7153. 13 indexed citations

18.

Wang, Chenglong, Peili Wang, Hao Xu, et al.. (2015). Resting heart rate associates with one-year risk of major adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention. Experimental Biology and Medicine. 241(5). 478–484. 18 indexed citations

19.

Wang, Chenglong. (2013). Prokaryotic Expression and Antigenicity Analysis of N-terminal of Mycoplasma ovipneumoniae P113 Protein. 1 indexed citations

20.

Li, Yongqiang, Mei Jin, Tiangang Zhu, et al.. (2009). Effect of Chinese drugs for supplementing qi, Nourishing Yin and activating blood circulation on myocardial perfusion in patients with acute myocardial infarction after revascularization. Chinese Journal of Integrative Medicine. 15(1). 19–25. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact